Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENFORCE PLUS: J&J COVID-19 Vaccine Safety and Effectiveness
NCT06360744Phase 4Completed
- Start
- Jul 2021
- Primary completion
- Dec 2023
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Ad26.COV2.S in coronavirus disease 2019 (COVID-19). Started Jul 2021; status: completed.
02
Drugs
Ad26.COV2.S
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT06360744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06360744.